Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4548793
Max Phase: Preclinical
Molecular Formula: C57H64I4N8
Molecular Weight: 861.19
Molecule Type: Unknown
Associated Items:
ID: ALA4548793
Max Phase: Preclinical
Molecular Formula: C57H64I4N8
Molecular Weight: 861.19
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCCCCCCCCCCCC[n+]1ccc(-c2c3nc(c(-c4cc[n+](C)cc4)c4ccc([nH]4)c(-c4cc[n+](C)cc4)c4nc(c(-c5cc[n+](C)cc5)c5ccc2[nH]5)C=C4)C=C3)cc1.[I-].[I-].[I-].[I-]
Standard InChI: InChI=1S/C57H63N8.4HI/c1-5-6-7-8-9-10-11-12-13-14-15-16-33-65-40-31-45(32-41-65)57-52-23-21-50(60-52)55(43-27-36-63(3)37-28-43)48-19-17-46(58-48)54(42-25-34-62(2)35-26-42)47-18-20-49(59-47)56(51-22-24-53(57)61-51)44-29-38-64(4)39-30-44;;;;/h17-32,34-41H,5-16,33H2,1-4H3,(H,58,59,60,61);4*1H/q+3;;;;/p-3/b54-46-,54-47-,55-48-,55-50-,56-49-,56-51-,57-52-,57-53-;;;;
Standard InChI Key: DZMDSOVRERQVFE-QZIDOGQLSA-K
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 861.19 | Molecular Weight (Monoisotopic): 860.5232 | AlogP: 11.79 | #Rotatable Bonds: 17 |
Polar Surface Area: 72.88 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 4.74 | CX LogP: -3.65 | CX LogD: -3.65 |
Aromatic Rings: 7 | Heavy Atoms: 65 | QED Weighted: 0.07 | Np Likeness Score: 0.08 |
1. Ferino A, Nicoletto G, D'Este F, Zorzet S, Lago S, Richter SN, Tikhomirov A, Shchekotikhin A, Xodo LE.. (2020) Photodynamic Therapy for ras-Driven Cancers: Targeting G-Quadruplex RNA Structures with Bifunctional Alkyl-Modified Porphyrins., 63 (3): [PMID:31930916] [10.1021/acs.jmedchem.9b01577] |
Source(1):